ACE Reports.
Make a selection below to explore our full database of 5 results on the topic: "J Zanchetta"
ACE Reports
(5 Reports)ACE Reports
(5 Reports)
Metabolic Disorders
Denosumab is superior to alendronate for improving cortical bone porosity post-menopause
Bone. 2014 Feb;59:173-9. doi: 10.1016/j.bone.2013.11.016. Epub 2013 Nov 22.
Metabolic Disorders
WCO-IOF: Changes with QCT, DXA, and TBS between denosumab, alendronate, & placebo
Metabolic Disorders
Parathyroid Hormone effective in fracture prevention in postmenopausal osteoporotic women
Ann Intern Med. 2007 Mar 6;146(5):326-39
General Orthopaedics
Denosumab reduces risk of fractures in post-menopausal women
N Engl J Med. 2009 Aug 20;361(8):756-65. Epub 2009 Aug 11.
Metabolic Disorders
Tibolone reduces fracture risk in osteoporotic women but increases stroke risk
N Engl J Med. 2008 Aug 14;359(7):697-708